Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Blood|September 7, 2010
Detection of a novel truncating Merkel cell polyomavirus large T antigen deletion in chronic lymphocytic leukemia cellsN Deepa Pantulu, Christian P Pallasch, Anna Kordelia Kurz, et al.International Journal of Cancer|July 30, 2010
Sustained NF-kappaB activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 (A20) locusLukas P Frenzel, Rainer Claus, Nadine Plume, et al.Blood|August 29, 2012
B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramidesJanine Schwamb, Valeska Feldhaus, Michael Baumann, et al.EMBO Molecular Medicine|March 12, 2015
A DNA/HDAC dual-targeting drug CY190602 with significantly enhanced anticancer potencyChuan Liu, Hongyu Ding, Xiaoxi Li, et al.Communications Biology|June 5, 2023
Functional impact and molecular binding modes of drugs that target the PI3K isoform p110δFloyd Hassenrück, Maria Farina-Morillas, Lars Neumann, et al.Blood|February 12, 2015
miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in CLLValeska Berg, Marion Rusch, Nachiket Vartak, et al.Journal of Autoimmunity|September 23, 2021
Kinase activity profiling reveals contribution of G-protein signaling modulator 2 deficiency to impaired regulatory T cell migration in rheumatoid arthritisAnja Meyer, Shuaifeng Yan, Viktoria Golumba-Nagy, et al.Oncogene|April 10, 2012
Rapid generation of human B-cell lymphomas via combined expression of Myc and Bcl2 and their use as a preclinical model for biological therapiesIlya Leskov, Christian P Pallasch, Adam Drake, et al.Cancers|August 23, 2020
Macrophage-Mediated Antibody Dependent Effector Function in Aggressive B-Cell Lymphoma Treatment is Enhanced by Ibrutinib via Inhibition of JAK2Verena Barbarino, Sinika Henschke, Stuart James Blakemore, et al.Sports Medicine - Open|March 4, 2026
Innovative Exercise in Routine Cancer Care: Insights from Eight Years of Integrated Oncological Exercise Therapy (OTT)Timo Sonntag, Ariana Safi, Vera Coutellier, et al.Pageof 3